The Zebrafish (Danio rerio) In Vivo Model for Preclinical Toxicity Testing
Zebrafish: The alternative vertebrate animal model
The zebrafish is emerging as a complement to existing in vitro technologies and established preclinical in vivo models that can be scaled for high throughput. Technological innovation has helped the zebrafish embryo gain ground as a disease model and an assay system for drug screening.
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Tags: Zebrafish | Danio rerio | preclinical toxicity | preclinical toxicity testing | Biobide | transgenic lines | High Throughput Screening | animal model | toxicology | drug discovery | in vitro technologies | in vivo models
To receive the white paper on this topic please submit your information in the form below.
By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.
-
Predictive Toxicology Summit
Boston, MA
May 21- 23, 2012 -
Exploring Challenges and Opportunities in Predictive Safety Tools: Trends from Industry-Wide Surveys
January 13, 2012
Register Now -
hESC derived Cytiva™ Cardiomyocytes for Drug Safety Testing
March 28, 2012
Register Now -
Improving Solubility
Venue to be confirmed, Munich, Germany
June 26- 28, 2012
-
Europe Remains Most Important for Patent Strategies for 83.3% of Pharma Firms
Right across the global pharmaceutical industry, companies are desperately seeking to diversify their... Read more
Pharma IQ






Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!